Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD (Q34183741)

31 July 2017

Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD (English)

1 reference

attention deficit hyperactivity disorder

31 July 2017

1 reference

1 reference

5

Robert L Findling

1 reference

31 July 2017

6

Sharon B Wigal

1 reference

31 July 2017

3

Matthew Brams

1 reference

31 July 2017

Scott H Kollins

1

1 reference

31 July 2017

Rakesh Jain

series ordinal

2

1 reference

31 July 2017

Scott Segal

series ordinal

4

1 reference

31 July 2017

Moise Khayrallah

series ordinal

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

9 May 2011

1 reference

31 July 2017

1 reference

31 July 2017

127

1 reference

31 July 2017

6

1 reference

31 July 2017

e1406-13

1 reference

Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Treatment of ADHD in children with tics: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387872

Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21555501

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Symptom profiles in children with ADHD: effects of comorbidity and gender

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21555501

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21555501

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1542/PEDS.2010-1260

1 reference

31 July 2017

1 reference

31 July 2017

1 reference